This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Miner, M. Search for Related Content Social Bookmarking                         What's this?

Patient Education: Preventing Progression of Type 2 Diabetes: The Reflex to Use Pharmacological Therapy

Swansea Family Practice Group, Swansea, Massachusetts, Martin_Miner{at}Brown.edu

Primary care providers are often neglectful of lifestyle interventions in the management of the progression of glucose intolerance to type 2 diabetes. Several studies have examined the benefits of pharmacologic therapy in conjunction with lifestyle modification to delay or retard this progression. This article focuses on 3 of these studies: the DREAM trial, the ADOPT trial, and the Finnish Diabetes Study. All reinforce the use and effectiveness of thiazolidinediones in the prevention of progression, yet active lifestyle intervention complements and maintains a lower diabetes risk over time.

Key Words: type 2 diabetes • lifestyle interventions • prevention of diabetes

American Journal of Lifestyle Medicine, Vol. 1, No. 5, 358-359 (2007)
DOI: 10.1177/1559827607304489.


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?